These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 2071077

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Modulation of myocardial energetics: emerging evidence for a therapeutic target in cardiovascular disease.
    Morrow DA, Givertz MM.
    Circulation; 2005 Nov 22; 112(21):3218-21. PubMed ID: 16301353
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Enhanced inotropic state of the failing left ventricle by cardiac contractility modulation electrical signals is not associated with increased myocardial oxygen consumption.
    Butter C, Wellnhofer E, Schlegl M, Winbeck G, Fleck E, Sabbah HN.
    J Card Fail; 2007 Mar 22; 13(2):137-42. PubMed ID: 17395055
    [Abstract] [Full Text] [Related]

  • 7. Clinical interventions for the preservation of ischemic myocardium.
    Rackley CE, Russell RO, Rogers WJ, Mantle JA, McDaniel HG, Reddy WJ.
    Cardiovasc Clin; 1981 Mar 22; 11(3):163-77. PubMed ID: 7011554
    [Abstract] [Full Text] [Related]

  • 8. [New aspects of the pathogenesis of heart failure].
    Erdmann E, Böhm M, Schwinger RH, Beuckelmann DJ.
    Internist (Berl); 1990 Oct 22; 31(10):632-40. PubMed ID: 2178156
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Metabolism in non-ischemic myocardium during coronary artery occlusion and reperfusion.
    Buxton DB, Mody FV, Krivokapich J, Schelbert HR.
    J Mol Cell Cardiol; 1993 Jun 22; 25(6):667-81. PubMed ID: 8411193
    [Abstract] [Full Text] [Related]

  • 11. [Study of the impact of intramyocardial implantation of stem cells on myocardial perfusion and contractility in patients with coronary heart disease concurrent with postinfarct cardiosclerosis and chronic heart failure].
    Rakhmat-Zade TM, Skridlevskaia EA, Samoĭlenko LA, Bugriĭ ME, Konopliannikov AG, Kolesnikova AI, Tripol'skaia LV, Veselova TN, Sinitsyn VE, Sergienko VB, Akchurin RS.
    Vestn Rentgenol Radiol; 2006 Jun 22; (5):9-14. PubMed ID: 17694813
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Causes of heart failure].
    Strauer BE.
    Verh Dtsch Ges Inn Med; 1991 Jun 22; 97():149-64. PubMed ID: 1808879
    [No Abstract] [Full Text] [Related]

  • 15. [Pathophysiology and pathobiochemistry of heart failure: the myocardium].
    Schultheiss HP.
    Verh Dtsch Ges Inn Med; 1991 Jun 22; 97():164-74. PubMed ID: 1808880
    [No Abstract] [Full Text] [Related]

  • 16. Continuous positive airway pressure decreases myocardial oxygen consumption in heart failure.
    Kaye DM, Mansfield D, Naughton MT.
    Clin Sci (Lond); 2004 Jun 22; 106(6):599-603. PubMed ID: 14756635
    [Abstract] [Full Text] [Related]

  • 17. [State of the myocardium in cardiac insufficiency in patients with ischemic heart disease].
    Almazov VA, Amineva KhK, Ermilov LP, Lapin VV, Mamaev NN.
    Vestn Akad Med Nauk SSSR; 1987 Jun 22; (9):47-52. PubMed ID: 3673229
    [No Abstract] [Full Text] [Related]

  • 18. [Comparative evaluation of the effect of halothane and enflurane on the myocardial function and metabolism in patients with ischemic heart disease].
    Vasil'ev AV, Lepilin MG.
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987 Jun 22; 10(2):87-90. PubMed ID: 3426825
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of cardiac insufficiency in ischemic heart disease].
    Broustet JP, Douard H, Koch M, Oysel N, Massière JP.
    Arch Mal Coeur Vaiss; 1990 Nov 22; 83(13):1941-8. PubMed ID: 2125413
    [Abstract] [Full Text] [Related]

  • 20. The negative impact of oxidative stress in chronic cardiac failure and coronary heart disease calls for a new pathophysiologic and therapeutic approach.
    Popovici D, Olinescu R, Hertoghe J.
    Rom J Endocrinol; 1992 Nov 22; 30(3-4):87-101. PubMed ID: 1339525
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.